| SARS-CoV-2 variants and their relevant mutational profiles: update summer 2021 M Alkhatib, V Svicher, R Salpini, FA Ambrosio, MC Bellocchi, L Carioti, ... Microbiology spectrum 9 (3), e01096-21, 2021 | 56 | 2021 |
| Update on SARS-CoV-2 omicron variant of concern and its peculiar mutational profile M Alkhatib, R Salpini, L Carioti, FA Ambrosio, S D’Anna, L Duca, G Costa, ... Microbiology spectrum 10 (2), e02732-21, 2022 | 54 | 2022 |
| Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B V Svicher, R Salpini, L Piermatteo, L Carioti, A Battisti, L Colagrossi, ... Gut 70 (12), 2337-2348, 2021 | 53 | 2021 |
| High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance V Malagnino, R Salpini, G Maffongelli, A Battisti, L Fabeni, L Piermatteo, ... PLoS One 13 (3), e0195045, 2018 | 28 | 2018 |
| Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids including bile in two patients with acute cholecystitis R Scutari, L Piermatteo, MC Manuelli, M Iannetta, R Salpini, A Bertoli, ... Life 10 (11), 302, 2020 | 21 | 2020 |
| Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure R Salpini, S D’Anna, L Benedetti, L Piermatteo, U Gill, V Svicher, ... Frontiers in microbiology 13, 972687, 2022 | 19 | 2022 |
| Neuro-axonal damage and alteration of blood–brain barrier integrity in COVID-19 patients MA Zingaropoli, M Iannetta, L Piermatteo, P Pasculli, T Latronico, ... Cells 11 (16), 2480, 2022 | 19 | 2022 |
| Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control R Salpini, M Alkhatib, G Costa, L Piermatteo, FA Ambrosio, VC Di Maio, ... Journal of Antimicrobial Chemotherapy 76 (2), 396-412, 2021 | 17 | 2021 |
| Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartment L Piermatteo, R Scutari, R Chirichiello, M Alkhatib, V Malagnino, A Bertoli, ... Methods 201, 74-81, 2022 | 15 | 2022 |
| New markers in monitoring the reactivation of hepatitis B virus infection in immunocompromised hosts V Svicher, R Salpini, V Malagnino, L Piermatteo, M Alkhatib, C Cerva, ... Viruses 11 (9), 783, 2019 | 15 | 2019 |
| An increase in the levels of middle surface antigen characterizes patients developing HBV-driven liver cancer despite prolonged virological suppression G Brancaccio, R Salpini, L Piermatteo, M Surdo, V Fini, L Colagrossi, ... Microorganisms 9 (4), 752, 2021 | 13 | 2021 |
| A snapshot of virological presentation and outcome of immunosuppression‐driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution … R Salpini, A Battisti, L Colagrossi, D Di Carlo, L Fabeni, L Piermatteo, ... Journal of Viral Hepatitis 26 (7), 846-855, 2019 | 11 | 2019 |
| HDV Can constrain HBV genetic evolution in HBsAg: Implications for the identification of innovative pharmacological targets L Colagrossi, R Salpini, R Scutari, L Carioti, A Battisti, L Piermatteo, ... Viruses 10 (7), 363, 2018 | 11 | 2018 |
| A hyper-glycosylation of HBV surface antigen correlates with HBsAg-negativity at immunosuppression-driven HBV reactivation in vivo and hinders HBsAg recognition in vitro R Salpini, L Piermatteo, A Battisti, L Colagrossi, M Aragri, K Yu La Rosa, ... Viruses 12 (2), 251, 2020 | 10 | 2020 |
| Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg … R Salpini, A Battisti, L Piermatteo, L Carioti, OE Anastasiou, US Gill, ... Emerging Microbes & Infections 9 (1), 928-939, 2020 | 10 | 2020 |
| Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/HBsag-negative patients with HIV infection by highly sensitive molecular assays, and can be … R Salpini, V Malagnino, L Piermatteo, T Mulas, M Alkhatib, R Scutari, ... Microorganisms 8 (11), 1819, 2020 | 9 | 2020 |
| Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis R Salpini, S D'Anna, L Piermatteo, V Svicher Journal of Viral Hepatitis 29 (12), 1038-1047, 2022 | 8 | 2022 |
| Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and … L Piermatteo, S D’Anna, A Bertoli, M Bellocchi, L Carioti, L Fabeni, ... Emerging Microbes & Infections 12 (1), 2219347, 2023 | 7 | 2023 |
| Establishment of a seronegative occult infection with an active hepatitis B virus reservoir enriched of vaccine escape mutations in a vaccinated infant after liver transplantation R Salpini, A Pietrobattista, L Piermatteo, MS Basso, MC Bellocchi, ... The Journal of Infectious Diseases 220 (12), 1935-1939, 2019 | 6 | 2019 |
| GS-17-the integration of Hepatitis B virus into human genome is a common event in the setting of HBeAg negative disease: implications for the treatment and management of CHB V Svicher, R Salpini, A Battisti, L Colagrossi, L Piermatteo, M Surdo, ... Journal of Hepatology 70 (1), e83-e84, 2019 | 5 | 2019 |
